Sonova United States Hearing Instruments LLC
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Sonova United States Hearing Instruments LLC
Live alerts from global media, monitored by Business Radar
2025-02-06 (jomfruland.net)
Sonova Holding: Why high roe of this stock may not signal growth -
Son's holding has a strong return on its own capital (ROE) of 25 %, which exceeds the average of 12 %. The company has seen a slight profit growth of 4.2 % in the last five years, which significantly lags behind the growth rate of the 11 % industry. Medini's payment ratio of SONOVA payments of 43 % suggests a balanced approach between paying dividends and reinvestics into growth. Analysts predict a future ROE of 27 %, which arises as to its correlation with profit growth. Investors should monitor Son's strategies for capital allocation and growth to assess its long -term potential. Sonova holding shares can be the last
Read more
2025-01-30 (pando.life)
Hearing auxiliary equipment market growth, prediction 2025 2032 《Pando》
Rovj3gerson posted. The “Hearing Service Market Market” prioritizes coast management and improving efficiency. In addition, the report is both the market demand and the supply aspects. The hearing auxiliary equipment market is expected to grow from 2025 to 7.4% at annual rate. The whole reoperation is 143 pages. Hearing auxiliary equipment Market analysis * * E guzo ...
Read more
2024-11-23 (hearinghealthmatters.org)
Phonak Infinio Helps Boost Sales for Sonova in First Half of 2024/25
Sonova Holding AG announced its first-half results for the 2024/25 financial year, showcasing robust sales growth amidst challenging market conditions. The company achieved sales of CHF 1,833.2 million (~USD $2,033.5 million), marking a 5.9% increase in local currencies, driven by strong performances in its Hearing Instruments and Cochlear Implants segments. Performance Highlights The Hearing Instruments segment reported sales of CHF ...
Read more
2024-11-19 (proinvestor.com)
Swiss rival to Demant and GN is growing nicely in a difficult market
The world's largest hearing aid manufacturer, Switzerland's Sonova, which competes with both GN and Demant, had to contend with weak market conditions, but could still see sales grow across its global markets in the first half of its financial year 2024/25. Here the growth is attributed, among other things, to the launch of the two new top products, Phonak Infino and Phonak Sphere Infinio. On the other hand, operations could not keep up with expectations in the market, and this affects the share in Tuesday's trading on the stock exchange in Zurich. Here, Sonova fell by 1.5 percent on Tuesday morning. to 312.10 Swiss francs.- We achieved solid sales growth in the first half of the year despite weaker market conditions than expected, says Arnd Kaldowski, CEO of Sonova, in the accounts. Sales grew in the half year to 1833.2 million Swiss francs from 1753 million Swiss francs in the same period the previous year. This corresponds to an increase of 5.9 per cent.
Read more
2024-02-20 (cash.ch)
Stock market ticker: Swiss stock exchange without a clear trend - Sandoz in the red due to rating reduction - analyst sees industrial stocks another 31 percent higher after price jump
The Swiss stock market opened little changed on Tuesday.
Read more
2023-11-21 (handelszeitung.ch)
Sonova suffers a decline in profits in the first half of the year and lowers its outlook
The hearing aid manufacturer Sonova suffered a decline in both sales and net profit in the first half of its 2023/24 financial year.
Read more
2016-06-07 (reuters.com)
CORRECTED-Hearing aid group William Demant looks for more retail deals
Hearing aid maker William Demant is looking for more retail acquisitions to increase control over the sale of its products and fight competition from discount chains such as Costco.
Read more